$PCRX
Pacira BioSciences, Inc. Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000139681421000014 Filed on March 01, 2021

Income Statement

Concept	2020 Q4	2020 Q3	2020 Q2
Revenue	$131.0M	$117.5M	$75.51M
YoY Change	6.98%	12.23%	-26.41%
Cost Of Revenue	$35.30M	$29.99M	$22.31M
YoY Change	10.64%	34.47%	-11.49%
Gross Profit	$95.68M	$87.49M	$53.20M
YoY Change	5.7%	6.2%	-31.27%
Gross Profit Margin	73.05%	74.47%	70.46%
Selling, General & Admin	$52.80M	$52.56M	$43.34M
YoY Change	-2.58%	4.85%	-11.77%
% of Gross Profit	55.19%	60.08%	81.47%
Research & Development	$15.30M	$14.65M	$13.62M
YoY Change	-22.34%	-27.67%	-23.6%
% of Gross Profit	15.99%	16.75%	25.6%
Depreciation & Amortization	$5.060M	$3.100M	$3.000M
YoY Change	-0.59%	-13.89%	-14.29%
% of Gross Profit	5.29%	3.54%	5.64%
Operating Expenses	$70.10M	$67.21M	$56.96M
YoY Change	-41.93%	-34.28%	-41.47%
Operating Profit	$25.58M	$17.62M	-$7.147M
YoY Change	-184.71%	630.21%	-235.49%
Interest Expense	-$6.400M	$7.132M	$5.456M
YoY Change	48.84%	20.07%	-7.18%
% of Operating Profit	-25.02%	40.48%
Other Income/Expense, Net	$300.0K	-$11.47M	-$164.0K
YoY Change	-133.33%	39.39%	-96.05%
Pretax Income	$12.70M	$6.150M	-$7.311M
YoY Change	-462.86%	-205.74%	-748.71%
Income Tax	-$1.800M	-$124.0M	-$42.00K
% Of Pretax Income	-14.17%	-2016.26%
Net Earnings	$14.51M	$130.1M	-$7.269M
YoY Change	-396.93%	-2237.65%	-366.26%
Net Earnings / Revenue	11.08%	110.75%	-9.63%
Basic Earnings Per Share	$0.33	$3.03	-$0.17
Diluted Earnings Per Share	$0.32	$2.94	-$0.17
COMMON SHARES
Basic Shares Outstanding	43.44M shares	42.93M shares	42.22M shares
Diluted Shares Outstanding		44.28M shares	42.22M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$521.7M	$532.1M	$326.8M
YoY Change	78.66%	100.34%	11.84%
Cash & Equivalents	$99.96M	$125.2M	$78.55M
Short-Term Investments	$421.7M	$406.9M	$248.2M
Other Short-Term Assets	$12.30M	$11.70M	$18.30M
YoY Change	13.89%	12.5%	115.29%
Inventory	$64.65M	$68.54M	$66.69M
Prepaid Expenses
Receivables	$53.05M	$46.14M	$44.01M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$651.6M	$658.5M	$455.8M
YoY Change	59.49%	73.82%	15.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$136.7M	$125.5M	$113.3M
YoY Change	30.58%	19.71%	7.4%
Goodwill	$99.55M	$99.50M	$99.50M
YoY Change	0.0%	-0.05%	-1.03%
Intangibles	$96.52M	$98.49M	$100.5M
YoY Change	-7.54%	-7.4%	-7.26%
Long-Term Investments	$109.5M	$12.80M	$10.00M
YoY Change	995.0%	-84.41%	-76.42%
Other Assets	$106.2M	$104.1M
YoY Change
Total Long-Term Assets	$622.9M	$561.7M	$410.3M
YoY Change	47.43%	31.05%	4.34%
TOTAL ASSETS
Total Short-Term Assets	$651.6M	$658.5M	$455.8M
Total Long-Term Assets	$622.9M	$561.7M	$410.3M
Total Assets	$1.275B	$1.220B	$866.1M
YoY Change	53.36%	51.12%	9.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.43M	$13.01M	$9.160M
YoY Change	-18.5%	-19.02%	-31.37%
Accrued Expenses	$70.97M	$60.40M	$47.68M
YoY Change	0.78%	-0.98%	-8.14%
Deferred Revenue
YoY Change
Short-Term Debt	$149.6M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$149.6M
YoY Change
Total Short-Term Liabilities	$253.3M	$86.27M	$70.58M
YoY Change	135.28%	-9.98%	-14.96%
LONG-TERM LIABILITIES
Long-Term Debt	$313.0M	$456.5M	$314.2M
YoY Change	2.29%	51.11%	5.37%
Other Long-Term Liabilities	$3.832M	$4.219M	$2.984M
YoY Change	155.13%	81.85%	-66.82%
Total Long-Term Liabilities	$3.832M	$4.219M	$2.984M
YoY Change	155.13%	81.85%	-66.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$253.3M	$86.27M	$70.58M
Total Long-Term Liabilities	$3.832M	$4.219M	$2.984M
Total Liabilities	$654.8M	$635.6M	$478.0M
YoY Change	37.53%	37.77%	7.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$253.9M	-$268.4M	-$398.5M
YoY Change	-36.44%	-31.97%	2.6%
Common Stock	$44.00K	$43.00K	$43.00K
YoY Change	4.76%	2.38%	2.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$619.7M	$584.7M	$388.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.275B	$1.220B	$866.1M
YoY Change	53.36%	51.12%	9.93%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	$14.51M	$130.1M	-$7.269M
YoY Change	-396.93%	-2237.65%	-366.26%
Depreciation, Depletion And Amortization	$5.060M	$3.100M	$3.000M
YoY Change	-0.59%	-13.89%	-14.29%
Cash From Operating Activities	$46.66M	$39.79M	-$15.63M
YoY Change	80.15%	116.72%	-168.67%
INVESTING ACTIVITIES
Capital Expenditures	-$14.41M	-$7.760M	-$8.910M
YoY Change	220.22%	388.05%	334.63%
Acquisitions
YoY Change
Other Investing Activities	-$67.91M	-$195.1M	$45.03M
YoY Change	158.21%	-2802.08%	-125.05%
Cash From Investing Activities	-$82.32M	-$202.9M	$36.13M
YoY Change	167.27%	-3703.02%	-119.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.36M	209.8M	3.460M
YoY Change	-612.87%	14671.83%	-7.49%
NET CHANGE
Cash From Operating Activities	46.66M	39.79M	-15.63M
Cash From Investing Activities	-82.32M	-202.9M	36.13M
Cash From Financing Activities	10.36M	209.8M	3.460M
Net Change In Cash	-25.30M	46.70M	23.96M
YoY Change	265.61%	83.79%	-115.43%
FREE CASH FLOW
Cash From Operating Activities	$46.66M	$39.79M	-$15.63M
Capital Expenditures	-$14.41M	-$7.760M	-$8.910M
Free Cash Flow	$61.07M	$47.55M	-$6.720M
YoY Change	100.89%	138.35%	-127.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201602Member
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-35060
CY2020	dei	Entity Registrant Name EntityRegistrantName	PACIRA BIOSCIENCES, INC.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	51-0619477
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Sylvan Way, Suite 300
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Parsippany,
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07054
CY2020	dei	City Area Code CityAreaCode	(973)
CY2020	dei	Local Phone Number LocalPhoneNumber	254-3560
CY2020	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2020	dei	Trading Symbol TradingSymbol	PCRX
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	1600000000	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43863467	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99957000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78228000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	421705000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	213722000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	53046000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	104387000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47530000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	64650000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	58296000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12265000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10781000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	651623000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	408557000	USD
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	95459000	USD
CY2019Q4	us-gaap	Long Term Investments LongTermInvestments	64798000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	136688000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104681000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	74492000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38124000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	96521000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	106164000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2020Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	14019000	USD
CY2019Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	10971000	USD
CY2020Q4	us-gaap	Assets Assets	1274513000	USD
CY2019Q4	us-gaap	Assets Assets	831065000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10431000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12799000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70974000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70427000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7425000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4935000	USD
CY2020Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	149648000	USD
CY2019Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2020Q4	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	14736000	USD
CY2019Q4	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	18179000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	114000	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1333000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	253328000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	107673000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	313030000	USD
CY2019Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	306045000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	71025000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	40938000	USD
CY2020Q4	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	13610000	USD
CY2019Q4	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	19963000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3832000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1502000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	654825000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	476121000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43636929	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43636929	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41908148	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41908148	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	44000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	42000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	873201000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	753978000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-253875000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399398000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	318000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	322000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	619688000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	354944000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1274513000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	831065000	USD
CY2020	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	0	USD
CY2019	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	0	USD
CY2018	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3000000	USD
CY2020	us-gaap	Revenues Revenues	429647000	USD
CY2019	us-gaap	Revenues Revenues	421026000	USD
CY2018	us-gaap	Revenues Revenues	337277000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	117328000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	106712000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	86845000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	59421000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	72119000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55688000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	193516000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	200782000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	177265000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7866000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5703000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2020	pcrx	Acquisition Related Charges Product Discontinuation And Other Expenses AcquisitionRelatedChargesProductDiscontinuationAndOtherExpenses	5166000	USD
CY2019	pcrx	Acquisition Related Charges Product Discontinuation And Other Expenses AcquisitionRelatedChargesProductDiscontinuationAndOtherExpenses	25230000	USD
CY2018	pcrx	Acquisition Related Charges Product Discontinuation And Other Expenses AcquisitionRelatedChargesProductDiscontinuationAndOtherExpenses	1564000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	383297000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	410546000	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	321362000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	46350000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	10480000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	15915000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	4629000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	7376000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	6497000	USD
CY2020	us-gaap	Interest Expense InterestExpense	25671000	USD
CY2019	us-gaap	Interest Expense InterestExpense	23628000	USD
CY2018	us-gaap	Interest Expense InterestExpense	21949000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8071000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2852000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4976000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-888000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-26261000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21228000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16340000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20089000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10748000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-425000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-125434000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	268000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	145523000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.41
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.33
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42671000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41513000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40911000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43682000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41513000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40911000	shares
CY2020	us-gaap	Net Income Loss NetIncomeLoss	145523000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2020	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-3000	USD
CY2019	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	602000	USD
CY2018	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	174000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	602000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	174000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	145519000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10414000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-297000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	279483000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7170000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1784000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31725000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	174000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	321226000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8469000	USD
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2402000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33650000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	602000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	354944000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	45229000	USD
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2546000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39920000	USD
CY2020	pcrx	Deferred Tax Expense Associated To The Equity Component Of Convertible Debt DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt	20450000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	145523000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	619688000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	145523000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-126613000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1828000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19908000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19576000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13165000	USD
CY2020	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	2156000	USD
CY2019	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1707000	USD
CY2018	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1590000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18254000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13746000	USD
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12799000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-22000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1010000	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-65000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-8071000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	39920000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	33650000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	31725000	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	5204000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	16672000	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	1618000	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4315000	USD
CY2018	us-gaap	Gain Loss On Investments GainLossOnInvestments	-854000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5516000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8524000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5999000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6353000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8026000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7157000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	739000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3885000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3228000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3312000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1822000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-573000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5999000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	22041000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5203000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2467000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-6726000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	897000	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	9409000	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	370000	USD
CY2018	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	77032000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	70520000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48870000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	117691000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37801000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10159000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14514000	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	546516000	USD
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	318484000	USD
CY2018	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	363255000	USD
CY2020	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	307870000	USD
CY2019	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	319468000	USD
CY2018	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	405188000	USD
CY2020	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	0	USD
CY2019	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	0	USD
CY2018	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	6843000	USD
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1160000	USD
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1622000	USD
CY2018	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-277607000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-128488000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	20576000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	45218000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8469000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7170000	USD
CY2020	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	2546000	USD
CY2019	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	2402000	USD
CY2018	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	1784000	USD
CY2020	pcrx	Payments For Debt Conversion Premiums PaymentsForDebtConversionPremiums	0	USD
CY2019	pcrx	Payments For Debt Conversion Premiums PaymentsForDebtConversionPremiums	233000	USD
CY2018	pcrx	Payments For Debt Conversion Premiums PaymentsForDebtConversionPremiums	0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	12487000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	5591000	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	6630000	USD
CY2018	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	222304000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3670000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8954000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	21729000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-54298000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	78400000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78228000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54126000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99957000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78228000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	7205000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	8199000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	8205000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	2417000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	863000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	128000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9288000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3019000	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2894000	USD
CY2020	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	0	USD
CY2019	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	28470000	USD
CY2018	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	0	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, among other things, revenue recognition, stock-based compensation, inventory costs, impairments of equity investments, long-lived assets, goodwill, liabilities and accruals, including contingent consideration, convertible senior notes, and the valuation of deferred tax assets. The Company’s critical accounting policies are those that are both most important to the Company’s consolidated financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results could differ from these estimates.</span></div>
CY2019Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	51800000	USD
CY2019Q4	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue	6500000	USD
CY2020Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	28500000	USD
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2020	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	RECENT ACCOUNTING PRONOUNCEMENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-top:0.5pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. The Company now includes forward-looking information to better form its credit loss estimates. This update also required enhanced disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. This standard became effective for the Company beginning January 1, 2020 and there were no credit losses recognized upon adoption.</span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The update added the following disclosures: (i) changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The standard became effective for the Company beginning January 1, 2020 and the Company has applied these new disclosure requirements in its consolidated financial statements for the year ended December 31, 2020.</span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles—Goodwill and Other Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update provides guidance to determine which implementation costs to capitalize as they relate to the service contract and which costs to expense. Any expense related to the capitalized implementation costs should be recorded in the same financial statement line item in the consolidated statements of operations as the fees associated with the hosting element of the arrangement, and the payments for capitalized implementation costs should be classified in the same manner as payments made for fees associated with the hosting element in the consolidated statements of cash flows. This standard became effective for the Company beginning January 1, 2020. The amendments have been applied prospectively to implementation costs incurred after the date of adoption. The Company did not incur implementation costs in a hosting arrangement that were required to be capitalized during the year ended December 31, 2020.</span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was adopted by the Company on January 1, 2019 using the effective date method. There were practical expedients available to the Company that it elected to apply upon adoption. The Company did not re-assess (i) whether its contracts contained a lease under the new definition of a lease and (ii) the classification of those leases. There were no initial direct costs previously capitalized on the consolidated balance sheet. In addition, the Company applied hindsight in the determination of the lease terms, in the assessment of the likelihood that a lease renewal, termination or purchase option will be exercised, and in the assessment of any potential impairments that existed on the ROU assets recognized at adoption. The Company also elected not to recognize a ROU asset and lease liability for those leases with a remaining lease term of 12 months or less.</span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At adoption, the Company recorded $36.5 million of lease liabilities and $27.6 million of ROU assets as of January 1, 2019, the difference representing previously recorded lease-related assets and liabilities. There was a cumulative-effect adjustment to accumulated deficit of $0.2 million upon adoption. </span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2014, the FASB, issued ASU 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company adopted this standard on January 1, 2018 using the modified retrospective method and recorded a cumulative effect adjustment of $1.4 million to accumulated deficit upon adoption—the impact related to the acceleration of $1.0 million of deferred revenue and $0.4 million of royalties. The implementation of Accounting Standards Codification, or ASC, 606 did not have a material impact on the Company’s consolidated statements of operations because the timing of revenue recognition for EXPAREL product sales did not change. Refer to Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information on the Company’s revenue.</span></div><div style="margin-bottom:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the FASB issued ASU 2018-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which aligned accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. The Company adopted ASU 2018-07 in June 2018 and recorded a cumulative effect adjustment of less than $0.1 million to accumulated deficit upon adoption.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Not Adopted as of December 31, 2020</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows certain exceptions, including an exception to the use of the incremental approach for intra-period tax allocations, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and to reflect the effects of enacted changes in tax laws or rates in the annual effective tax rate computation from the date of enactment. Lastly, in any future acquisition, the Company would be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The standard became effective for the Company January 1, 2021 and the Company does not anticipate any material impact to its consolidated financial statements.</span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which limits the number of convertible instruments that require separate accounting to (i) those with embedded conversion features that are not clearly and closely related to the debt, that meet the definition of a derivative, and that do not qualify for the scope exception from derivative accounting and (ii) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid in capital. In addition, the new guidance requires diluted earnings per share calculations to be prepared using the if-converted method, instead of the treasury stock method. The guidance must be applied in fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, with early adoption permitted no earlier than for fiscal years beginning after December 15, 2020. The Company has the option to adopt the new guidance using a modified retrospective method of transition, which would then be applied to transactions outstanding at the time of adoption, or the full retrospective method. The Company is evaluating the impact from the adoption of ASU 2020-06 on its consolidated financial statements.</span></div>
CY2017Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3013000	USD
CY2018	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	19321000	USD
CY2018	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	19034000	USD
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3300000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	26951000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	25447000	USD
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4804000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	28117000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	28123000	USD
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4798000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	426614000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	418926000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	332427000	USD
CY2020	pcrx	Collaborative Arrangement Milestone Payments Additional Charge CollaborativeArrangementMilestonePaymentsAdditionalCharge	9700000	USD
CY2020Q4	pcrx	Collaborative Arrangement Milestone Payments To Be Received CollaborativeArrangementMilestonePaymentsToBeReceived	10000000.0	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	26886000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20019000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16266000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14407000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	21498000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	23870000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	64650000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	58296000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	215048000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	180121000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	78360000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	75440000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	136688000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104681000	USD
CY2020	us-gaap	Depreciation Depreciation	12000000.0	USD
CY2019	us-gaap	Depreciation Depreciation	14000000.0	USD
CY2018	us-gaap	Depreciation Depreciation	13200000	USD
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	2400000	USD
CY2018	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	700000	USD
CY2020Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2000000.0	USD
CY2019Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2500000	USD
CY2020	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	500000	USD
CY2020	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	100000	USD
CY2019	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	200000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	10055000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	6225000	USD
CY2018	us-gaap	Operating Lease Cost OperatingLeaseCost	7236000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	2096000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	1651000	USD
CY2018	us-gaap	Variable Lease Cost VariableLeaseCost	1761000	USD
CY2020	us-gaap	Lease Cost LeaseCost	12151000	USD
CY2019	us-gaap	Lease Cost LeaseCost	7876000	USD
CY2018	us-gaap	Lease Cost LeaseCost	8997000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	14347000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	7346000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	42191000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	41605000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y2M4D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M17D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0687
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0755
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	12527000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10423000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10697000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	10980000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	11271000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	50801000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	106699000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	28249000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	78450000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	62040000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	37507000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2020	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	0	USD
CY2020Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	110090000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	110090000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13569000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5703000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	96521000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	104387000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7900000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5700000	USD
CY2020Q4	pcrx	Finite Lived Intangible Assets Amortization Expense Per Year Period1 FiniteLivedIntangibleAssetsAmortizationExpensePerYearPeriod1	7900000	USD
CY2020Q4	pcrx	Finite Lived Intangible Assets Amortization Expense Per Year Period2 FiniteLivedIntangibleAssetsAmortizationExpensePerYearPeriod2	2200000	USD
CY2020Q4	pcrx	Accruedsellinggeneralandadministrativeexpenses Accruedsellinggeneralandadministrativeexpenses	23288000	USD
CY2019Q4	pcrx	Accruedsellinggeneralandadministrativeexpenses Accruedsellinggeneralandadministrativeexpenses	21695000	USD
CY2020Q4	pcrx	Accruedresearchanddevelopmentexpenses Accruedresearchanddevelopmentexpenses	6682000	USD
CY2019Q4	pcrx	Accruedresearchanddevelopmentexpenses Accruedresearchanddevelopmentexpenses	6562000	USD
CY2020Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	11196000	USD
CY2019Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	12955000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22202000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22258000	USD
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3040000	USD
CY2019Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2883000	USD
CY2020Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	2376000	USD
CY2019Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	2048000	USD
CY2020Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	2190000	USD
CY2019Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	2026000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70974000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70427000	USD
CY2020	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2020	pcrx	Deferred Tax Expense Associated To The Equity Component Of Convertible Debt DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt	20500000	USD
CY2020	pcrx	Amortization Period Of Transaction Costs Attributable To Liability Component Of Convertible Debt AmortizationPeriodOfTransactionCostsAttributableToLiabilityComponentOfConvertibleDebt	P5Y
CY2020	pcrx	Transaction Costs Attributable To The Equity Component Of Convertible Debt TransactionCostsAttributableToTheEquityComponentOfConvertibleDebt	2700000	USD
CY2017Q1	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2020	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7650000	USD
CY2019	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8195000	USD
CY2018	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8205000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2156000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1707000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1634000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	18254000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13746000	USD
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12799000	USD
CY2020	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	2389000	USD
CY2019	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	20000	USD
CY2018	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	689000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	25671000	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	23628000	USD
CY2018	us-gaap	Interest Expense Debt InterestExpenseDebt	21949000	USD
CY2020	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0715
CY2019	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2018	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2020Q4	us-gaap	Share Price SharePrice	59.84
CY2020Q4	pcrx	Total Milestone Payments Yet To Be Paid In Connection Acquisition TotalMilestonePaymentsYetToBePaidInConnectionAcquisition	58000000.0	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	516845000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	350000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	31000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	517164000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	278198000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	346000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	24000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	278520000	USD
CY2020Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	1600000	USD
CY2019Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	1400000	USD
CY2020	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2019	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43636929	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43636929	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41908148	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41908148	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
CY2019	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
CY2020	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
CY2019Q2	pcrx	Sharebased Compensation Arrangementby Sharebased Payment Award Increase In Numberof Shares Authorized SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseInNumberofSharesAuthorized	3000000	shares
CY2020Q4	pcrx	Employee Stock Purchase Plan Espp Sharesin Espp EmployeeStockPurchasePlanESPPSharesinESPP	500000	shares
CY2020Q4	pcrx	Maximum Fair Market Value Purchaseof Espp Shares MaximumFairMarketValuePurchaseofESPPShares	25000	USD
CY2020Q4	pcrx	Employee Stock Purchase Planfairvalue EmployeeStockPurchasePlanfairvalue	0.85
CY2020	pcrx	Stock Purchased And Issued During Period Shares Employee Stock Purchase Plans StockPurchasedAndIssuedDuringPeriodSharesEmployeeStockPurchasePlans	61585	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	13106701	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	11606389	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1500312	shares
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39920000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33650000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31725000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39920000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33650000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31725000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8578000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2018	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	145523000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42671000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41513000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40911000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43682000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41513000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40911000	shares
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.41
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.33
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4352000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7044000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6065000	shares
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	17000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7026000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5169000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3089000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3722000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5594000	USD
CY2020	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	20089000	USD
CY2019	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-10748000	USD
CY2018	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-425000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-6000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-96000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1185000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2096000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	142000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1179000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2096000	USD
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-6.2439
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	46000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-99164000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1828000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-27449000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-126613000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1828000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-125434000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	268000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-125400000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0315
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0733
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.2484
CY2020	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	0.0318
CY2019	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0395
CY2018	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.9204
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-6.4787
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1976
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	3.6927
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0108
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.1053
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	8.7429
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0792
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.1993
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-7.0035
CY2020	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	0
CY2019	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	0
CY2018	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	2.1847
CY2020	pcrx	Effect Of State Blended Tax Rate Changes Expense Benefit EffectOfStateBlendedTaxRateChangesExpenseBenefit	0
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	129091000	USD
CY2019	pcrx	Effect Of State Blended Tax Rate Changes Expense Benefit EffectOfStateBlendedTaxRateChangesExpenseBenefit	-0.0042
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0249
CY2018	pcrx	Effect Of State Blended Tax Rate Changes Expense Benefit EffectOfStateBlendedTaxRateChangesExpenseBenefit	0.1344
CY2020	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	-0.0522
CY2019	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0
CY2018	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0455
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.1358
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-1.3296
CY2020	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	0.0766
CY2019	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	-0.1541
CY2018	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	-2.0298
CY2020	pcrx	Effective Income Tax Rate Reconciliation338g Election Percent EffectiveIncomeTaxRateReconciliation338gElectionPercent	0
CY2019	pcrx	Effective Income Tax Rate Reconciliation338g Election Percent EffectiveIncomeTaxRateReconciliation338gElectionPercent	-0.0961
CY2018	pcrx	Effective Income Tax Rate Reconciliation338g Election Percent EffectiveIncomeTaxRateReconciliation338gElectionPercent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0184
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0235
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0615
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-6.2439
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0249
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1073
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1073
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-126600000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-126600000	USD
	pcrx	Deferred Tax Expense Associated To The Equity Component Of Convertible Debt DeferredTaxExpenseAssociatedToTheEquityComponentOfConvertibleDebt	20500000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	66123000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	68921000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	17335000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	16895000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	13473000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	15778000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	7254000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	8767000	USD
CY2020Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	21862000	USD
CY2019Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	23187000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1345000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1646000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2138000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2022000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	129530000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	137216000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	20851000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	8125000	USD
CY2020Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	108679000	USD
CY2019Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	129091000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2515000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	106164000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2600000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1600000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020	pcrx	Minimum Cumulative Percentage Of Change In Ownership As Condition To Offset Taxable Income Or Tax MinimumCumulativePercentageOfChangeInOwnershipAsConditionToOffsetTaxableIncomeOrTax	0.50
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-126600000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7000000.0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1500000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6100000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4537000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1539000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6076000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2900000	USD
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	200000	USD
CY2020	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	200000	USD
CY2019	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	200000	USD
CY2018	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	1600000	USD
CY2019	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	5300000	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	2077000	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	1564000	USD
CY2018	us-gaap	Payments For Restructuring PaymentsForRestructuring	1402000	USD
CY2018	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	13000	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	2252000	USD
CY2019	us-gaap	Restructuring Charges RestructuringCharges	847000	USD
CY2019	us-gaap	Payments For Restructuring PaymentsForRestructuring	752000	USD
CY2019	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	193000	USD
CY2019	us-gaap	Restructuring Reserve Translation And Other Adjustment RestructuringReserveTranslationAndOtherAdjustment	-1515000	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	639000	USD
CY2020	us-gaap	Restructuring Charges RestructuringCharges	-38000	USD
CY2020	us-gaap	Payments For Restructuring PaymentsForRestructuring	582000	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	19000	USD
CY2020	pcrx	Collaborative Arrangement Option To Extend Term CollaborativeArrangementOptionToExtendTerm	P5Y
CY2019Q1	pcrx	Litigation Investigation Term LitigationInvestigationTerm	P5Y
CY2019	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	3500000	USD
CY2020Q1	us-gaap	Revenues Revenues	105684000	USD
CY2020Q2	us-gaap	Revenues Revenues	75505000	USD
CY2020Q3	us-gaap	Revenues Revenues	117484000	USD
CY2020Q4	us-gaap	Revenues Revenues	130974000	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	29732000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	2730000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	22305000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	29993000	USD
CY2020Q4	us-gaap	Cost Of Revenue CostOfRevenue	35298000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	88590000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	82652000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	99864000	USD
CY2020Q4	us-gaap	Costs And Expenses CostsAndExpenses	112191000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	8159000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-7269000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	130119000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	14514000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.03
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.94
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2019Q1	us-gaap	Revenues Revenues	91313000	USD
CY2019Q2	us-gaap	Revenues Revenues	102604000	USD
CY2019Q3	us-gaap	Revenues Revenues	104685000	USD
CY2019Q4	us-gaap	Revenues Revenues	122424000	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	27303000	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	25201000	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	22304000	USD
CY2019Q4	us-gaap	Cost Of Revenue CostOfRevenue	31904000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	90234000	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	97329000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	102272000	USD
CY2019Q4	us-gaap	Costs And Expenses CostsAndExpenses	120711000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2771000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6087000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-4888000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12

Files In Submission

Name	View Source	Status
0001396814-21-000014-index-headers.html	Edgar Link	pending
0001396814-21-000014-index.html	Edgar Link	pending
0001396814-21-000014.txt	Edgar Link	pending
0001396814-21-000014-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pcrx-12312020xex211.htm	Edgar Link	pending
pcrx-12312020xex231.htm	Edgar Link	pending
pcrx-12312020xex311.htm	Edgar Link	pending
pcrx-12312020xex312.htm	Edgar Link	pending
pcrx-12312020xex321.htm	Edgar Link	pending
pcrx-20201231.htm	Edgar Link	pending
pcrx-20201231.xsd	Edgar Link	pending
pcrx-20201231_cal.xml	Edgar Link	unprocessable
pcrx-20201231_def.xml	Edgar Link	unprocessable
pcrx-20201231_g1.jpg	Edgar Link	pending
pcrx-20201231_g2.jpg	Edgar Link	pending
pcrx-20201231_g3.jpg	Edgar Link	pending
pcrx-20201231_htm.xml	Edgar Link	completed
pcrx-20201231_lab.xml	Edgar Link	unprocessable
pcrx-20201231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira BioSciences, Inc. Stock $pcrx

2020 Q4 Form 10-K Financial Statement

#000139681421000014 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira BioSciences, Inc. Stock $pcrx

2020 Q4 Form 10-K Financial Statement

#000139681421000014 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira BioSciences, Inc. Stock $pcrx